Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKinsey
Moodys
Colorcon
Express Scripts

Last Updated: February 4, 2023

Apomorphine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for apomorphine hydrochloride and what is the scope of patent protection?

Apomorphine hydrochloride is the generic ingredient in three branded drugs marketed by Sunovion Pharms Inc, Mdd Us, and Sage Chems, and is included in three NDAs. There are nineteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Apomorphine hydrochloride has two hundred and forty-nine patent family members in twenty-five countries.

There are three drug master file entries for apomorphine hydrochloride. Three suppliers are listed for this compound.

Recent Clinical Trials for apomorphine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
William Ondo, MDPhase 4
SunovionPhase 4
Rennes University HospitalPhase 4

See all apomorphine hydrochloride clinical trials

Pharmacology for apomorphine hydrochloride
Drug Class Dopaminergic Agonist
Mechanism of ActionDopamine Agonists
Medical Subject Heading (MeSH) Categories for apomorphine hydrochloride

US Patents and Regulatory Information for apomorphine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Pharms Inc KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-005 May 21, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sunovion Pharms Inc KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-004 May 21, 2020 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sunovion Pharms Inc KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-004 May 21, 2020 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sunovion Pharms Inc KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-001 May 21, 2020 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sunovion Pharms Inc KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-003 May 21, 2020 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sunovion Pharms Inc KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-004 May 21, 2020 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sunovion Pharms Inc KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-001 May 21, 2020 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for apomorphine hydrochloride

International Patents for apomorphine hydrochloride

Country Patent Number Title Estimated Expiration
China 101316579 Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions See Plans and Pricing
European Patent Office 3735988 FILMS SUBLINGUES (SUBLINGUAL FILMS) See Plans and Pricing
Mexico 2013006911 PELICULAS SUB-LINGUALES. (SUBLINGUAL FILMS.) See Plans and Pricing
Canada 2456234 INSTRUMENTS OPTIQUES ACCORDABLES (TUNABLE OPTICAL INSTRUMENTS) See Plans and Pricing
Austria 536868 See Plans and Pricing
Canada 2544776 FILMS A BASE D'OXYDE DE POLYETHYLENE ET SYSTEMES D'ADMINISTRATION DE MEDICAMENTS EN ETANT FAITS (POLYETHYLENE OXIDE-BASED FILMS AND DRUG DELIVERY SYSTEMS MADE THEREFROM) See Plans and Pricing
Canada 2821756 FILMS SUBLINGUAUX (SUBLINGUAL FILMS) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Boehringer Ingelheim
Dow
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.